Coiled Therapeutics Commences Trading on AIM After Raising £8.5 Million
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowCoiled Therapeutics has officially started trading on the AIM market following a successful capital raise of £8.5 million. This funding aims to support the company's ongoing research and development initiatives. The initiation of trading marks a significant step for Coiled Therapeutics, which could impact investor perception in the biotech sector. Such fundraising events often influence stock liquidity and market participation.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News
Gene Editing Develops Crops That Signal Stress to Farmers
Oct 21
Anthropic Reports $16.3B Revenue in Preliminary S-1 IPO Filing
Oct 20
Artificial Intelligence Claude Used by Wall Street to Design Drug Sparks New Thesis
Oct 20
Jio Platforms IPO Anchor Book Oversubscribed 30x at $26.3B Bids
Oct 20